The Safety of Tiotropium — The FDA's Conclusions

  • Michele T
  • Pinheiro S
  • Iyasu S
99Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

In any field, improving performance and accountability depends on having a shared goal that unites the interests and activities of all stakeholders. In health care, however, stakeholders have myriad, often conflicting goals, including access to services, profitability, high quality, cost containment, safety, convenience, patient-centeredness, and satisfaction. Lack of clarity about goals has led to divergent approaches, gaming of the system, and slow progress in performance improvement. Achieving high value for patients must become the overarching goal of health care delivery, with value defined as the health outcomes achieved per dollar spent.(1) This goal is what matters for patients and unites . . .

Cited by Powered by Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Michele, T. M., Pinheiro, S., & Iyasu, S. (2010). The Safety of Tiotropium — The FDA’s Conclusions. New England Journal of Medicine, 363(12), 1097–1099. https://doi.org/10.1056/nejmp1008502

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 20

47%

Researcher 11

26%

Professor / Associate Prof. 10

23%

Lecturer / Post doc 2

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 43

86%

Agricultural and Biological Sciences 4

8%

Social Sciences 2

4%

Pharmacology, Toxicology and Pharmaceut... 1

2%

Article Metrics

Tooltip
Mentions
News Mentions: 1
References: 1
Social Media
Shares, Likes & Comments: 456

Save time finding and organizing research with Mendeley

Sign up for free